Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEC121120 in Healthy Subjects and Chronic Hepatitis B Patients
NCT04536532Phase 2Terminated
- Sponsor
- Sunshine Lake Pharma
- Start
- Oct 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pibothiadine in Chronic Hepatitis B (CHB), sponsored by Sunshine Lake Pharma. Started Oct 2020; status: terminated.
02
Drugs
pibothiadine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT04536532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536532.